Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system

Carolyn L. Westhoff, Lisa M. Keder, Angelina Gangestad, Stephanie B. Teal, Andrea I. Olariu, Mitchell D. Creinin

Research output: Contribution to journalArticle

Abstract

Objective: To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). Study Design: We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (aged 16–45 years, n = 1751) in an ongoing 10-year phase-3 trial. Results: Over six years, nine pregnancies occurred (none in year 6) for a life-table pregnancy rate of 0.87 (95% CI 0.44–1.70). Adverse event rates remain low through 6 or more years of use. Two expulsions occurred in year 6. Conclusion: This levonorgestrel 52 mg IUS is a highly effective and safe contraceptive over 6 years of use. Implications: The levonorgestrel 52 mg IUS shows high 6-year contraceptive efficacy and a low rate of adverse events through 6 or more years of use.

Original languageEnglish (US)
JournalContraception
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Levonorgestrel
Contraceptive Agents
Pregnancy Rate
Safety
Life Tables
Pregnancy

Keywords

  • Efficacy
  • Intrauterine system
  • Levonorgestrel
  • Liletta
  • Safety

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system. / Westhoff, Carolyn L.; Keder, Lisa M.; Gangestad, Angelina; Teal, Stephanie B.; Olariu, Andrea I.; Creinin, Mitchell D.

In: Contraception, 01.01.2019.

Research output: Contribution to journalArticle

Westhoff, Carolyn L. ; Keder, Lisa M. ; Gangestad, Angelina ; Teal, Stephanie B. ; Olariu, Andrea I. ; Creinin, Mitchell D. / Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system. In: Contraception. 2019.
@article{34f9e2df4a2f44c89e5ae35c7b26942c,
title = "Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system",
abstract = "Objective: To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). Study Design: We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (aged 16–45 years, n = 1751) in an ongoing 10-year phase-3 trial. Results: Over six years, nine pregnancies occurred (none in year 6) for a life-table pregnancy rate of 0.87 (95{\%} CI 0.44–1.70). Adverse event rates remain low through 6 or more years of use. Two expulsions occurred in year 6. Conclusion: This levonorgestrel 52 mg IUS is a highly effective and safe contraceptive over 6 years of use. Implications: The levonorgestrel 52 mg IUS shows high 6-year contraceptive efficacy and a low rate of adverse events through 6 or more years of use.",
keywords = "Efficacy, Intrauterine system, Levonorgestrel, Liletta, Safety",
author = "Westhoff, {Carolyn L.} and Keder, {Lisa M.} and Angelina Gangestad and Teal, {Stephanie B.} and Olariu, {Andrea I.} and Creinin, {Mitchell D.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.contraception.2019.10.010",
language = "English (US)",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",

}

TY - JOUR

T1 - Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system

AU - Westhoff, Carolyn L.

AU - Keder, Lisa M.

AU - Gangestad, Angelina

AU - Teal, Stephanie B.

AU - Olariu, Andrea I.

AU - Creinin, Mitchell D.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective: To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). Study Design: We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (aged 16–45 years, n = 1751) in an ongoing 10-year phase-3 trial. Results: Over six years, nine pregnancies occurred (none in year 6) for a life-table pregnancy rate of 0.87 (95% CI 0.44–1.70). Adverse event rates remain low through 6 or more years of use. Two expulsions occurred in year 6. Conclusion: This levonorgestrel 52 mg IUS is a highly effective and safe contraceptive over 6 years of use. Implications: The levonorgestrel 52 mg IUS shows high 6-year contraceptive efficacy and a low rate of adverse events through 6 or more years of use.

AB - Objective: To assess 6-year contraceptive efficacy and safety of a levonorgestrel 52 mg intrauterine system (IUS). Study Design: We assessed pregnancy rates through 72 months in women aged 16–35 years at enrollment and safety in all participants (aged 16–45 years, n = 1751) in an ongoing 10-year phase-3 trial. Results: Over six years, nine pregnancies occurred (none in year 6) for a life-table pregnancy rate of 0.87 (95% CI 0.44–1.70). Adverse event rates remain low through 6 or more years of use. Two expulsions occurred in year 6. Conclusion: This levonorgestrel 52 mg IUS is a highly effective and safe contraceptive over 6 years of use. Implications: The levonorgestrel 52 mg IUS shows high 6-year contraceptive efficacy and a low rate of adverse events through 6 or more years of use.

KW - Efficacy

KW - Intrauterine system

KW - Levonorgestrel

KW - Liletta

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=85076574430&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85076574430&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2019.10.010

DO - 10.1016/j.contraception.2019.10.010

M3 - Article

C2 - 31786203

AN - SCOPUS:85076574430

JO - Contraception

JF - Contraception

SN - 0010-7824

ER -